If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
115.05    0.40 (0.35%)
Bid:
114.55
Ask:
114.60
Spread: 0.05 (0.044%)
Market Cap: £66.93b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Final Terms

5 Mar 2024 12:21

RNS Number : 6652F
Lloyds Banking Group PLC
05 March 2024

5 March 2024

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 1 March 2024, for the ?500,000,000 Floating Rate Callable Notes due 2027 (the "Notes") issued by Lloyds Banking Group plc pursuant to the base prospectus dated 30 June 2023, as supplemented by the supplementary prospectuses dated 26 July 2023, 25 October 2023 and 23 February 2024 (together, the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended).

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6652F_1-2024-3-5.pdf

A copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel: +44 20 7356 1571

Email: douglas.radcliffe@lloydsbanking.com

Group Corporate Affairs:

Matt Smith

Head of Media Relations

Tel: +44 (0) 7788 352 487

Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plc

Registered Office

The MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in the Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II/UK MiFIR (Product Governance) professionals/ECPs-only / No EU or UK PRIIPs KID - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs or UK PRIIPs key information document (KID) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
PFTBDGDXGDGDGSU
Date   Source Headline
12th Mar 20255:44 pmRNSTransaction in Own Shares
11th Mar 20256:11 pmRNSTransaction in Own Shares
11th Mar 20254:31 pmRNSDirector/PDMR Shareholding
10th Mar 20255:48 pmRNSTransaction in Own Shares
10th Mar 20252:00 pmRNSDirector/PDMR Shareholding
7th Mar 20255:40 pmRNSTransaction in Own Shares
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
6th Mar 20255:45 pmRNSTransaction in Own Shares
6th Mar 20253:30 pmRNSDirector/PDMR Shareholding
5th Mar 20255:33 pmRNSTransaction in Own Shares
4th Mar 20255:54 pmRNSTransaction in Own Shares
4th Mar 20254:07 pmRNSPublication of Final Terms
3rd Mar 20255:39 pmRNSTransaction in Own Shares
28th Feb 20256:18 pmRNSTransaction in Own Shares
28th Feb 20252:40 pmRNSTotal Voting Rights
28th Feb 20251:21 pmRNSPublication of Suppl.Prospcts
28th Feb 202512:28 pmRNSPublication of Suppl.Prospcts
27th Feb 20256:16 pmRNSTransaction in Own Shares
27th Feb 20253:44 pmRNS2024 Form 20F Filed
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 202512:00 pmRNSDirector/PDMR Shareholding
27th Feb 20259:05 amRNS2024 Annual Report and Accounts
25th Feb 20256:22 pmRNSTransaction in Own Shares
24th Feb 20255:50 pmRNSTransaction in Own Shares
24th Feb 202512:27 pmRNSDirector/PDMR Shareholding
21st Feb 20255:56 pmRNSTransaction in Own Shares
21st Feb 202512:54 pmRNSPublication of Suppl.Prospcts
21st Feb 20257:10 amRNSCommencement of Share Buyback Programme
21st Feb 20257:00 amRNS2024 Form 20F Filed
20th Feb 20257:00 amRNS2024 Results
20th Feb 20257:00 amRNS2024 Annual Report and Accounts
18th Feb 202510:33 amRNSNotice of Redemption
17th Feb 20259:05 amRNSNotification of Redemption
17th Feb 20258:46 amRNSNotification of Redemption
11th Feb 20252:53 pmRNSDirector/PDMR Shareholding
3rd Feb 202510:57 amRNSNotification of Redemption
31st Jan 20254:05 pmRNSTotal Voting Rights
13th Jan 20251:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSBlock listing Interim Review
31st Dec 202410:02 amRNSTotal Voting Rights
20th Dec 20242:00 pmRNSDirector/PDMR Shareholding
20th Dec 202412:44 pmRNSNOTICE TO COVERED BONDHOLDERS
19th Dec 20248:41 amRNSNotification of Redemption
11th Dec 20242:16 pmRNSDirector/PDMR Shareholding
29th Nov 20243:08 pmRNSTotal Voting Rights
29th Nov 202411:37 amRNSNotice of Redemption
27th Nov 202410:20 amRNSNotice of Redemption
26th Nov 20249:00 amRNSBlock Listing of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.